Lexaria Bioscience (LEXX) Other Operating Expenses (2017 - 2022)
Lexaria Bioscience's Other Operating Expenses history spans 6 years, with the latest figure at $1.5 million for Q3 2022.
- On a quarterly basis, Other Operating Expenses changed N/A to $1.5 million in Q3 2022 year-over-year; TTM through May 2023 was $1.5 million, a N/A change, with the full-year FY2022 number at $1.5 million, changed 0.0% from a year prior.
- Other Operating Expenses hit $1.5 million in Q3 2022 for Lexaria Bioscience, roughly flat from $1.5 million in the prior quarter.
- Over the last five years, Other Operating Expenses for LEXX hit a ceiling of $1.5 million in Q1 2021 and a floor of -$247835.0 in Q4 2020.
- Historically, Other Operating Expenses has averaged $686245.9 across 5 years, with a median of $769583.0 in 2019.
- Biggest five-year swings in Other Operating Expenses: soared 25846.55% in 2019 and later tumbled 132.2% in 2020.
- Tracing LEXX's Other Operating Expenses over 5 years: stood at $627731.0 in 2018, then grew by 22.6% to $769583.0 in 2019, then tumbled by 132.2% to -$247835.0 in 2020, then soared by 714.4% to $1.5 million in 2021, then changed by 0.0% to $1.5 million in 2022.
- Business Quant data shows Other Operating Expenses for LEXX at $1.5 million in Q3 2022, $1.5 million in Q1 2021, and -$247835.0 in Q4 2020.